When did Medtronic report Q2 2025 earnings?

Medtronic (MDT) reported Q2 2025 earnings on November 19, 2024 before market open.

What were Medtronic's Q2 2025 revenue and EPS?

Medtronic reported revenue of $8.4B and diluted EPS of $1.26 for Q2 2025.

Did Medtronic beat estimates in Q2 2025?

Revenue beat the consensus estimate of $8.3B by $128.3M. EPS beat the consensus estimate of $1.25 by $0.01.

Where can I find Medtronic's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001613103-24-000165) directly on SEC EDGAR. The filing index links above go to sec.gov.

Medtronic MDT Q2 2025 earnings

Reported November 19, 2024 · Before market open

Revenue$8.4BBeat by $128.3M Diluted EPS$1.26Beat by $0.01

Revenue estimate$8.3B

EPS estimate$1.25

Next report

Aug 18, 2026 (in 2 months)

Revenue estimate$9.6B

EPS estimate$1.39

Financials

Q2 2025

Income statement

See full

Revenue$8.4B+5.2%

Gross profit$5.5B+4.5%

Operating income$1.6B+19.0%

Net income$1.3B+39.7%

EPS (diluted)$0.99+45.6%

Balance sheet

See full

Cash & equivalents$1.4B+6.3%

Total debt$28.4B+12.9%

Total equity$48.5B-5.8%

Total assets$90.0B0.0%

Cash flow

See full

Operating cash flow$958.0M+44.9%

CapEx$404.0M-12.4%

Free cash flow$554.0M+177%

Valuation & ratios

Valuation

as of 10/25/24

See full

Market cap$115.43B+23.0%

Enterprise value$142.41B+21.0%

P/E26.9×+4.0×

P/S3.5×+0.6×

Profitability

See full

Gross margin65%-0.4pp

Operating margin16.4%-1.0pp

Net margin13%+0.2pp

FCF margin16.7%+4.0pp

Returns & leverage

See full

Return on equity8.6%+0.6pp

Debt / equity0.6×+0.1×

Current ratio1.8×-0.4×

Segments

By segment

See full

Cardiovascular$3.1B+6.1%

Neuroscience$2.5B+7.1%

Medical Surgical$2.1B+1.2%

Diabetes$686.0M+12.5%

Other operating segment$37.0M-39.3%

By geography

See full

United States$4.3B—

Ireland$29.0M—

Versus estimates

Revenue

Q4 2026$9.8BBeat by $192.1M Q3 2026$9.0BBeat by $106.1M Q2 2026$9.0BBeat by $94.0M Q1 2026$8.6BBeat by $199.4M Q4 2025$8.9BBeat by $108.4M Q3 2025$8.3BMiss by $35.4M

Diluted EPS

Q4 2026$0.96Miss by $0.58 Q3 2026$1.36Beat by $0.02 Q2 2026$1.36Beat by $0.05 Q1 2026$1.26Beat by $0.03 Q4 2025$1.62Beat by $0.04 Q3 2025$1.39Beat by $0.03

Ask the moment Medtronic reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Medtronic report Q2 2025 earnings?: Medtronic (MDT) reported Q2 2025 earnings on November 19, 2024 before market open.
What were Medtronic's Q2 2025 revenue and EPS?: Medtronic reported revenue of $8.4B and diluted EPS of $1.26 for Q2 2025.
Did Medtronic beat estimates in Q2 2025?: Revenue beat the consensus estimate of $8.3B by $128.3M. EPS beat the consensus estimate of $1.25 by $0.01.
Where can I find Medtronic's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001613103-24-000165) directly on SEC EDGAR. The filing index links above go to sec.gov.